Results
|
5061.
|
|
|
5062.
|
|
|
5063.
|
|
|
5064.
|
|
|
5065.
|
|
|
5066.
|
Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor. [electronic resource] by
- Li, Z
- Shimada, Y
- Kawabe, A
- Sato, F
- Maeda, M
- Komoto, I
- Hong, T
- Ding, Y
- Kaganoi, J
- Imamura, M
Producer: 20010503
In:
Carcinogenesis vol. 22
Availability: No items available.
|
|
5067.
|
|
|
5068.
|
|
|
5069.
|
|
|
5070.
|
|
|
5071.
|
|
|
5072.
|
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib. [electronic resource] by
- Vincenzi, Bruno
- Santini, Daniele
- Russo, Antonio
- Addeo, Raffaele
- Giuliani, Francesco
- Montella, Liliana
- Rizzo, Sergio
- Venditti, Olga
- Frezza, Anna Maria
- Caraglia, Michele
- Colucci, Giuseppe
- Del Prete, Salvatore
- Tonini, Giuseppe
Producer: 20100504
In:
The oncologist vol. 15
Availability: No items available.
|
|
5073.
|
|
|
5074.
|
Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. [electronic resource] by
- Fournier, Laure S
- Oudard, Stephane
- Thiam, Rokhaya
- Trinquart, Ludovic
- Banu, Eugeniu
- Medioni, Jacques
- Balvay, Daniel
- Chatellier, Gilles
- Frija, Guy
- Cuenod, Charles A
Producer: 20100924
In:
Radiology vol. 256
Availability: No items available.
|
|
5075.
|
|
|
5076.
|
|
|
5077.
|
|
|
5078.
|
|
|
5079.
|
Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. [electronic resource] by
- Ding, Qingqing
- Huo, Longfei
- Yang, Jer-Yen
- Xia, Weiya
- Wei, Yongkun
- Liao, Yong
- Chang, Chun-Ju
- Yang, Yan
- Lai, Chien-Chen
- Lee, Dung-Fang
- Yen, Chia-Jui
- Chen, Yun-Ju Rita
- Hsu, Jung-Mao
- Kuo, Hsu-Ping
- Lin, Chun-Yi
- Tsai, Fuu-Jen
- Li, Long-Yuan
- Tsai, Chang-Hai
- Hung, Mien-Chie
Producer: 20080908
In:
Cancer research vol. 68
Availability: No items available.
|
|
5080.
|
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. [electronic resource] by
- Rini, Brian I
- Escudier, Bernard
- Tomczak, Piotr
- Kaprin, Andrey
- Szczylik, Cezary
- Hutson, Thomas E
- Michaelson, M Dror
- Gorbunova, Vera A
- Gore, Martin E
- Rusakov, Igor G
- Negrier, Sylvie
- Ou, Yen-Chuan
- Castellano, Daniel
- Lim, Ho Yeong
- Uemura, Hirotsugu
- Tarazi, Jamal
- Cella, David
- Chen, Connie
- Rosbrook, Brad
- Kim, Sinil
- Motzer, Robert J
Producer: 20111212
In:
Lancet (London, England) vol. 378
Availability: No items available.
|